Literature DB >> 29154536

Caged Naloxone: Synthesis, Characterization, and Stability of 3- O-(4,5-Dimethoxy-2-nitrophenyl)carboxymethyl Naloxone (CNV-NLX).

Anita H Lewin1, Scott E Fix1, Desong Zhong1, Louise D Mayer1, Jason P Burgess1, S Wayne Mascarella1, P Anantha Reddy1, Herbert H Seltzman1, F Ivy Carroll1.   

Abstract

The photolabile analogue of the broad-spectrum opioid antagonist naloxone, 3- O-(4,5-dimethoxy-2-nitrophenyl)carboxymethyl naloxone (also referred to as "caged naloxone", 3- O-(α-carboxy-6-nitroveratryl)naloxone, CNV-NLX), has been found to be a valuable biochemical probe. While the synthesis of CNV-NLX is simple, its characterization is complicated by the fact that it is produced as a mixture of α R,5 R,9 R,13 S,14 S and α S,5 R,9 R,13 S,14 S diastereomers. Using long-range and heteronuclear NMR correlations, the 1H NMR and 13C NMR resonances of both diastereomers have been fully assigned, confirming the structures. Monitoring of solutions of CNV-NLX in saline buffer, in methanol, and in DMSO has shown CNV-NLX to be stable for over a week under fluorescent laboratory lights at room temperature. Exposure of such solutions to λ 365 nm from a hand-held UV lamp led to the formation of naloxone and CNV-related breakdown products.

Entities:  

Keywords:  3-O-(α-carboxy-6-nitroveratryl)naloxone; diastereomers; photolabile

Mesh:

Substances:

Year:  2017        PMID: 29154536     DOI: 10.1021/acschemneuro.7b00378

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  2 in total

1.  Photolysis of dimethoxynitrobenzyl-"caged" acids yields fluorescent products.

Authors:  Aleksey Yu Vorob'ev; Tatyana Yu Dranova; Alexander E Moskalensky
Journal:  Sci Rep       Date:  2019-09-17       Impact factor: 4.379

2.  Physical Compatibility and Chemical Stability of Fentanyl and Naloxone Hydrochloride in 0.9% Sodium Chloride Injection Solution for Patient-Controlled Analgesia Administration.

Authors:  Peng Chen; Fuchao Chen; Jiexin Lei; Benhong Zhou
Journal:  Drug Des Devel Ther       Date:  2020-10-09       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.